IC 302-2022: Hype, Promise, and Reality: Orthopedic Use of Biologics in 2022-Hype, Promise, and Reality: Orthopedic Use of Biologics in 2022 (2/5)

Hype, Promise, and Reality: Orthopedic Use of Biologics in 2022 (2/5)

Video Transcription

Video Summary

The video discusses the use of orthobiologics in orthopedic surgery and the potential business opportunities associated with it. The speaker highlights the market size and growth of this field, emphasizing the need for such treatments due to the increasing number of people with conditions like osteoarthritis. They discuss the different rules and codes for billing these treatments, including government and commercial payers, as well as whether they are performed in the office or operating room. The speaker also mentions the importance of obtaining proper documentation and informed consent, and recommends consulting with individual carriers for coverage information. The use of specific codes for different orthobiologic treatments is also explained, as well as the need to avoid double billing and be cautious with marketing claims. Overall, the video encourages orthopedic surgeons to stay informed and compliant with the regulations surrounding orthobiologics. No specific credits were mentioned in the transcript.

Asset Caption

Louis McIntyre, MD

Keywords

orthobiologics

orthopedic surgery

business opportunities

osteaoarthritis

regulations